Mobile

A research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asth...

Update Il y a 4 ans
Reference: EUCTR2015-000716-18

A research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

- To demonstrate the superiority of CHF 5993 100/6/12.5 pMDI compared to CHF 1535 100/6 pMDI in terms of change from baseline in pre-dose FEV1 at Week 26. - To demonstrate the reduction of moderate and severe asthma exacerbations rate with CHF 5993 100/6/12.5 pMDI compared to CHF 1535 100/6 pMDI during the entire 52-week treatment period.

Inclusion criteria

  • uncontrolled asthma

Links